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CHAPTER 1: INTRODUCTION
Foster care youth frequently experience maltreatment and traumatic experiences;
oftentimes this leads to emotional and behavioral issues. National survey data on youth in child
welfare suggests that nearly half of youth in the foster care system have clinically significant
emotional or behavioral issues (Burns et al., 2004; Leslie, Hurlburt, Landsverk, Barth, &
Slymen, 2004). Experiences of youth in care include abuse, neglect, domestic violence, and
poverty. Youth in care often have histories of complex trauma due to abuse, neglect, domestic
violence, and poverty. Greeson et al. defines complex trauma as recurrent interpersonal
distressing or disturbing events early in life, oftentimes perpetuated by caregivers (2011). This
definition is further defined as experiencing two or more traumatic experiences. These traumatic
experiences include: sexual abuse, physical abuse, emotional abuse, neglect, or domestic abuse
(Kisiel et al., 2001) Studies indicate that high prevalence of trauma exposure are associated with
increased risk of negative mental health outcomes. These outcomes include, but are not limited
to, internalizing issues, severe post-trauma stress, and at least one psychological diagnosis
(Greeson et al., 2011).
Many foster care youth are medicated due to the complex trauma they experience. These
youth are documented to be medicated at two to three times the rate as their non-foster peers
(e.g. Leslie et al., 2011; Zito et al., 2003). In addition to the high rates of medication prescription
to address symptoms of mental disorders, research has depicted that prescription of multiple
medications (polypharmacy) is also a common occurrence in foster care. Zito and colleagues
(2008) assert that most foster youth are prescribed two or more medications and multiple
medication classes were being prescribed for the same psychiatric diagnoses.
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Polypharmacy is an increasingly utilized practice that may lead to overmedication. Overmedication can broadly be defined as exceeding the recommended dosages for psychotropic
medications per the standards set forth by the FDA. Yet these guidelines do not go far enough,
especially when practices of polypharmacy are in use. States having varying and changing
standards of what overmedication looks like for youth in care. There is also concern that
psychiatric medications are prescribed to youth as a behavioral control rather than to reduce
symptoms of mental disorders. In one study, two-thirds (67.2%) of clinicians believed that
medications were often used as a substitute for other treatments (Moses & Kirk, 2006). Other
research suggests reducing medications does not increase the incidence of misconduct (Bellonci
et al., 2013); yet there continue to be high prevalence rates of youth on medications in residential
treatment facility and foster placements.
Importance of the Study
Although there is research around rates of prevalence, polypharmacy, and medication
utilization in foster care placement (Leslie et al., 2011; Zito et al., 2008), there are few studies
that use case file review of child welfare records to understand the relationship between
medication use and negative behaviors. This relationship is important to study because the
incidence of negative behavior leads to placement instability (Rubin et al. 2004). Huefner et al.
(2012) uses case file review to assess medication utilization rates in relation to a treatment
progress checklist. In this study data was collected from a secure intensive residential treatment
center for youth ages 7-18. Huefner et al. (2012) sampled data from the first two weeks and last
two weeks of behavior while in residential treatment. While this methodology provides a
snapshot of pre and post services, it does not provide a time-lapsed view of behavior change.
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National attention to these concerns has prompted policies to promote informed consent
and understanding of medication management procedures, yet little research has been conducted
specific to youth experiences of polypharmacy or overmedication. This study will help to fill an
important gap in research around polypharmacy efficacy in youth in foster care and medication
reduction efficacy.
Purpose of the Current Research
The proposed study seeks to answer the question: What procedures and practices have
been performed related to medication use and behavior management in residential treatment
facilities? Specifically, this study seeks to understand how youth experience mental health and
medication services and determine the relationship between decreased medication use and
incidence of negative behavior.
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CHAPTER 2: LITERATURE REVIEW
Mental health is an important aspect of the overall health of any population. Mental
health is an area of particular interest in a vulnerable population such as foster care youth due to
increased incidence of violence and abuse. Nearly seventy five percent of youth entering foster
care exhibit behavioral and social problems that warrant mental health services (Landsverk et al.
2006). Due to the complexity of trauma experienced by youth in foster care, youth are likely to
experience placement instability (Rubin et al. 2004). A review of the literature will help
elucidate the issues around the mental health services of youth in foster care and the multitude of
mental health experiences that are an integral part of this lived experience.
Mental Health and Trauma
The experience of child maltreatment can profoundly affect emotional and behavioral
outcomes. Chronic abuse has a direct effect on the mental health and psycho-social outcomes of
foster youth such as substance abuse, criminal justice involvement, and lack of education (Garcia
et al., 2015). Greeson et al. (2011) examined trauma histories, trauma exposure, and
posttraumatic stress, and behavioral and emotional problems with 2,251 youth in foster care.
Seventy percent of the youth had experienced complex trauma or multiple interpersonal trauma
resulting in emotional, behavioral, interpersonal, psychological, and cognitive dysregulation
(Cook et al., 2005). Youth with complex trauma presented with much higher rates of
internalizing behaviors, and symptoms consistent with clinical diagnosis (Greeson et al., 2011).
Also, the rate of posttraumatic stress was found to be 1.5 times higher for youth who experienced
complex trauma. Complex trauma must be taken into consideration when assessing the mental
health needs of foster youth. Youth in foster care may present more behaviors as a result of the
trauma they have experienced. With this in mind, physicians possess much diagnostic discretion
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and should be cautious with diagnosis and consider the ecological and historical factors which
impact diagnosis and related treatment. Among foster care youth, presenting issues are a
significant predictor of psychotropic medication prescription (Warner, Song, & Pottick, 2014);
an understanding of whether complex trauma factors into the root causes of presenting problems
would serve to increase the efficacy of the prescribed treatment.
Garland and colleagues (1996) focused attention on the relationship between
maltreatment experiences and the mental health service utilization of youth post-placement.
More than 700 youth who were in placement at least 5 months, were assessed with the Child
Behavior Check (Achenbach, 1991) and caregiver interviews. Data for frequency of service
utilization, types of maltreatment, and patterns of maltreatment were also collected. In their
findings, the most common maltreatment experienced was neglect and caregiver absence, which
was experienced by 40% of the youth sampled. Though the pattern of neglect and caregiver
absence occurred most frequently within the sample, mental health service utilization occurred at
the lowest frequency rate for this maltreatment type. Youth who experienced abuse (physical,
sexual, or otherwise) presented with higher rates of mental health services utilization (x2(4)
44.26).
Overall results indicate that youth in foster care have a 56% mental health service
utilization rate within six months of removal from placement, which is 10 times the rate for
youth that have not been placed in foster care. Researchers suggested that this service utilization
might be indicative of foster care youth having multiple maltreatment experiences that have had
a compounding effect (Garland et al. 1996). They further note that complex maltreatment
experiences put youth at higher risk for maladaptive outcomes post-removal from foster care.
While the Garland et al. study was conducted with a large sample size, it is limited in that it only
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accounts for the experiences of youth in San Diego, California and may not be applicable to
other geographic locations. Furthermore, there is not an agreed upon way to access service
utilization data and, also, there a varied range of operational definitions for mental health
services.
Youth in foster care are also impacted by placement instability and possible ongoing
exposure to abuse, which has an impact on their mental health. Separation from families can be
a traumatic experience compounding the initial trauma maltreatment. Garcia et al. (2015), using
the Composite International Diagnostic Interview tool, interviewed 1,068 foster care alumni to
assess the effects of adverse childhood experiences on mental health outcomes. Findings
demonstrate the correlation between traumatic experiences such as placement instability and a
higher likelihood of a psychiatric diagnosis. Furthermore, findings indicate that poor mental
health of a parent and chronic abuse have a damaging effect on the mental health of foster care
alumni. This study garnered important themes of foster care youth with regard to mental health.
Though these findings provide a base of knowledge from a specific foster care treatment model,
the experiences in this placement may not reflect those of youth in alternative placements.
Assessment and Intervention
Complex trauma is experienced by many foster care youth, and its effects on mental
health are significant it is imperative to have access to appropriate assessment and treatment for
trauma experienced by foster youth.
Diagnosis. Scozzaro and Janikowski (2015) randomly selected 200 case files of youth
placed in foster care and created a survey for the respective caseworkers to complete regarding
the mental health of youth on their caseload. Of the 200 case files selected, 128 caseworkers
returned a completed survey for the selected files. Data from mental health diagnosis indicated
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that 59% of the sample population had a mental health diagnosis. This rate is consistent with
research findings over the past two decades, and is much higher than the estimated 13-20% of
the population of youth in the US, who have a mental health diagnosis (National Research
Council and Institute of Medicine, 2009). The researchers noted that the current body of research
indicates that 33% of the youth in foster care population have three or more mental health
diagnoses (Scozzaro and Janikowski, 2015).
Warner, Song, and Pottick (2014) collected data from youth receiving outpatient mental
health care across the United States in a federally funded study that used a two-stage sample
design. For their weighted sample of 92,810 youth in foster care, 99.6% were diagnosed with at
least one psychiatric diagnosis. Behavior disorders among youth in foster care were diagnosed as
the primary diagnosis for 34.9% of their sample (Warner et al. 2014). As a limitation of using
Medicaid data, only claims payable were included in their sample. Foltz and Huefner (2014)
sampled 74 youth placed in residential foster care, of which all of the youth sampled had at least
one psychiatric diagnosis. Although samples in these studies varied they indicate the high rate of
psychiatric diagnosis among foster care youth.
As much as half of the U.S. population meets diagnostic criteria for one or more mental
health disorder, at least once in their life span (Kessler & Wang, 2008). The Diagnostic and
Statistical Manual for Mental Disorder (DSM) provides a common language for diagnosis, yet
diagnosis itself can be subjective. This may be due to a therapist’s concept of how symptoms
should present, often without consideration of criteria that would exclude a child from diagnosis
(Bruchmüller, Margraf, & Schneider, 2012). To negate this kind of subjectively, Bruchmüller,
Margraf, and Schneider (2012) suggest further training to help avoid unnecessary biases in
diagnosis. Achenbach (2007) urges the importance of multiple assessment sources such as
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caregivers, teachers and children. This collaborative approach can ensure youth are being
diagnosed appropriately, where consideration is given to genetic makeup.
Treatment. Although multicomponent treatment best addresses the mental health needs
of youth (Scozzaro & Janikowski 2015) psychiatric medication often remains a first-line method
of treatment. Data from psychotropic medication use from Scozzaro and Janikowski’s (2015)
study indicated that 42% of their sample received medication as the only form of treatment. Only
25% of youth in various foster care placements were receiving both counseling and psychotropic
medication concurrently.
The general U.S. population of youth receive psychotropic medication at a rate of only
4%, yet Warner, Song, and Pottick (2014) found that in a weighted sample of the 92,810 youth in
foster care, 73% were prescribed one or more psychotropic medication but only 56.8% were
receiving individual therapy in addition to medication. Foltz and Huefner’s (2014) study found
an even higher rate of usage; of the 74 foster care youth in their sample, 86.6% were prescribed
at least one psychotropic medication, with 6.8% of youth in receipt of five or more medications.
These rates noted in the literature are significantly higher for foster care youth than non-foster
care youth. The researchers raised a question regarding the use of disparate assessments for
youth in care versus youth not in care. Implications of this study include a pressing need for
increased use of evidence-based treatments in least restrictive environments to promote positive
outcomes for foster care youth. This study provides a solid base of data with findings that are
comparable to national studies.
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Psychotropic Medication Prescription
The use of psychotropic medication for youth in foster care is a common and increasing
practice subject matter encompasses prevalence rates, safe and efficacy, adverse effects, and use
of polypharmacy practices.
Prevalence rates. In surveying the research around rates of medication among foster care
youth, various milieus have been studied including group homes, therapeutic foster care, nonfamilial foster care placement, and residential facilities. In a study examining both youth in
therapeutic foster care and foster youth in group homes facilities found that youth in group
homes are more likely to be prescribed psychotropic medications than their therapeutic foster
care peers. Breland-Noble et al. (2004) sampled 304 youth of which 184 were in therapeutic
foster care and 120 resided in group homes. They found that the use of psychotropic medication
was more frequent among youths under the age of 13. They found that of the youths placed in
therapeutic foster care 67% were taking psychotropic medications and 77% of youths in group
homes were actively taking psychotropic medications. Though this study sampled both
therapeutic and group home foster care youth, the difference across the two groups can only be
speculated. The sample population also included a large subsample of severely disturbed youth,
of which the study findings could not be generalizable to other residential settings.
Zito et al. (2003) assessed Medicaid data of psychotropic medication use for a 10 year
period from 1987 to 1996 for 900,000 youth under the age of 20. In their sample of Medicaid
enrollees from a Midwestern state, they found a 2-fold increase of psychotropic medication use
during the decade studied, with a prevalence rate of 28.3% in 1987 to a prevalence rate of 62.6%
in 1996. In their sample of Medicaid enrollees from a mid-Atlantic state, they found a 3-fold
increase, with a prevalence rate of 18.4% in 1987 to a prevalence rate of 61.6% in 1996. This
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research is crucial to the literature due to the sample population being both large and spread out
over the totality of 2 U.S. states, which greatly increases the ability of the findings to be
generalized to the population as a whole. Further, the longitudinal nature of the study is helpful
in identifying the trend toward increased psychotropic medication usage among youth. The trend
they noted in their conclusions was that throughout the 1990s, psychotropic medication
utilization rates among youth nearly reached adult utilization rates during the same period. While
these data provide a comprehensive addition to the research knowledge base, the rates may have
changed since this study was conducted.
Safety/efficacy. High rates of medication prescription has caused more attention to be
placed on the safety and efficacy of these medications for youth. In a study using National
Ambulatory Medical Care Survey data, Olfson, Blanco, Liu, Moreno, and Laje (2006) found that
between 1996 and 2000 the number of youth on Medicaid prescribed second-generation antipsychotic medications increased by 494%, and 160% for first-generation antipsychotic
medications. In light of this dramatic increase in second-generation antipsychotic use, Olfson and
collegues (2006) further data from the National Ambulatory Medical Care Survey, in 2000 to
2002, that medications accounted for 92% of medications prescribed to youth in office-based
practice. The researchers claim that there have been some recent clinical trials that provide some
support for short-term use of second-generation antipsychotics for psychosis and disruptive
behavior, however the researchers did not provide information regarding those clinical trials
(Olfson et al. 2006).Typical practice for youth psychotropic medication prescription is based on
studies and clinical experience for off-label use. Practicing evidence-based medicine should be
used to provide research-proven treatments (Brown, 2005).
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Adverse effects. In a study about atypical antipsychotic use among youth in Canada,
Panagiotopoulos, Ronsley, Elbe, Davidson, and Smith (2010) reviewed 42 randomized clinical
trials, finding five main areas of concerns regarding the use of atypical antipsychotic medications
of youth. The authors found that youth taking atypical antipsychotics had rapid increase in waist
circumference, which is an indicator of possible metabolic syndrome. In clinical trials of
olanzapine, clozapine, risperidone and quetiapine there was report of diabetes and diabetic
ketoacidosis in youth (Panagiotopoulos et al. 2010). Significant also, is that their review of
clinical trials found that atypical antipsychotics promote insulin resistance in youth. Lipids are
also another area of concern with evidence demonstrating an increase in cholesterol in youth
prescribed olanzapine and quetiapine. In clinical trials, youth ages 13 or older are more likely to
develop incident hypertension (Panagiotopoulos et al. 2010).
Youth taking atypical antipsychotics are more likely to develop metabolic syndrome,
which is when obesity is present with two other compounding factors present such as high blood
pressure, high triglycerides, low HDL- cholesterol, or high fasting glucose. Panagiotopoulos and
colleagues’ (2010) study provides a large body of information based on the comprehensive
review of over 40 randomized clinical trials. The researchers note that while there is a
preponderance of evidence refuting the efficacy of atypical antipsychotics with youth, there are
many other psychotropic medications, commonly prescribed, that are of interest particularly in
relation to their effects on youth (Panagiotopoulos et al. 2010). This study also brings to light
that many of these medications, while they may work for symptom management in the shortterm, have little or no empirical backing for long-term use in youth populations.
Adverse effects are possible with any psychotropic medication, but more health concerns
are present when potent or multiple psychotropic medications are being prescribed to youth

12

(Huefner, Griffith, Smith, Vollmer, & Leslie, 2014). Research offers a sobering look into the
detrimental effects psychotropic medication can have. Cummings (2012) cited some of the risks
of taking psychotropic medications ranging from constipation, restlessness, and fatigue. Of the
more serious complications caused by psychotropic mediations are impaired motor skills,
convulsions, liver damage, and suicidal thoughts. More rarely these medications can cause
tardive dyskinesia, which is a neurological disorder presenting with involuntary movements of
the face, mouth, tongue, and jaw.
Polypharmacy. Many topics are coalesced around this issue of increased psychotropic
use including the practice of polypharmacy (the practice of using multiple psychiatric
medications for a single diagnosis) or concomitant psychotropic mediation use (utilizing the
multiple classes of mediations for a diagnosis). In a 2011 study conducted by the Government
Accountability Office of the six selected states across the US, it was found that the prescribing of
psychotropic medications to youth in foster care did not meet established guidelines of American
Academy of Child and Adolescent Psychiatry. An extensive study was conducted assessing
Medicaid data from a sample of 472 foster care youth between the ages of 0 to 19 from a
southwestern US state. Zito et al. (2008) found that of the foster youth who were dispensed
psychotropic medications, 41.3% received three different classes of these medications during the
year sampled, and 15.9% received four different classes of medications concomitantly. In their
findings concomitant use of psychotropic medication, where three or more drug classes were
prescribed, varied little by diagnosis. The researchers suggest that this finding raises a question
of whether the medication is being prescribed on the basis of diagnosis or on the basis of
symptom presentation.
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In a therapeutic foster care sample of foster care youth, Brenner, Southerland, Burns,
Wagner, and Farmer (2004) assessed the medication use of 240 youth through foster parent
surveys. The targeted youth ranged in age from 2 to 21 years old. Surveys recorded medication
use of youth within the last two months of care. Among the sample youth, 142 (59.1%) took a
psychotropic medication within the last two months with 86 (60.6%) reporting taking two or
more medications. Among youth on psychotropic medication, approximately 40% were on one
medication, 36% were on two, and 25% were on three or more. There was a high use of
polypharmacy practices among this sample.
This phenomenon of polypharmacy was also reiterated in another recent study that found
that youth experience of antipsychotics was one of polypharmacy, where many youth had
exposure to several classes of psychotropic medications (Murphy et al., 2015) Interviews were
conducted with youth who had recent experience of taking antipsychotics. They were asked
question regarding their medication use. Many themes arose from the interviews ambivalence in
regards to medication use, desire for alternatives and gaps in support. Foltz and Huefner (2014)
cite that there is no evidence to support the use of three or more psychotropic medications in
youth. The authors further raised concerns regarding polypharmacy and the increased likelihood
of adverse events, competing neurochemical influences, and unknown outcomes for youth (Foltz
& Huefner 2014). The authors even went further to note that the practice of polypharmacy
should be carefully re-evaluated until safety can efficacy can be established (GAO, 2011).
Management/Stability
Management of mental health disorders in foster care must include explicit informed
consent, appropriate use of psychotropic medication, and adherence to policy and guidelines to
protect this vulnerable population. Appropriate monitoring and informed consent are also
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important considerations with psychotropic medication prescription.

Experts with the U.S.

Government Accountability Office (GAO; 2014) were enlisted to review 24 case files from five
states across the U.S. They assessed appropriateness of medication and dosage, justification for
concomitant medication prescription, informed consent practices, use of evidence-based
therapies, and oversight. In their findings, 13 of the 24 cases indicated appropriate prescription
monitoring by medical professionals, nine cases were partially monitored and two cases provided
no evidence of monitoring. Evidence for appropriate dosage among case files showed that 13
files had supportive evidence for dosage, while 11 cases were only partially supported by
documentation. Findings indicate that only five of the 20 cases utilizing practices of concomitant
medication use were mostly supported and 14 cases documented only partial support of
concomitant psychotropic medication prescription (GAO, 2014). Among informed consent data,
11 cases provided partial documentation for informed consent, while seven cases provided no
documentation of informed consent occurring. Evidence-based therapy use was determined to be
mostly provided in only three of the 15 cases (GAO, 2014).
Naylor et al. (2007) examined psychotropic medication consent and oversight for child
welfare-involved youth, through open-ended questionnaires sent to officials responsible for
mental health and medical policies or services in 29 states. Eight states require legal guardian or
parental consent, seven states require caseworker authorization, and six states require a court
order. The role and responsibilities for psychotropic medication management have not been
clearly defined, which complicates informed treatment (Cummings, 2012). Data collected for
psychotropic medication oversight indicate that 11 states have implemented monitoring
programs for psychotropic medication use while three states have created databases to monitor
psychotropic medication use. Naylor et al. 2007 discussed that improved oversight could have
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positive effects for continuity of care, placement stability, reduced need for hospitalization, and
decreased incidence of drug reactions and interactions.
Behavior management. Many foster youth exhibit externalizing behaviors which can be
disruptive and impact placement stability. Newton, Litrownik, and Landsverk (2000) assessed
the mental health experiences of youth in care to examine the relationship between negative
behaviors and placement instability. Their sample included 415 participants who remained in
care for at least five month from 1990 to 1991. They utilized The Child Behavior Check List
(Achenbach, 1991) to assess behavior problems. Information regarding change of placement was
taken from case records for the first 18 months after entering into care. Findings indicate a
correlation between placement instability and behavior problems of the 415 youth surveyed.
Their findings suggest that unstable placement histories have an effect on internalizing and
externalizing behaviors. Among the entire sample, externalizing behaviors were seen to be the
strongest indicator of placement change. These findings help elucidate problem behaviors
presented within the foster care treatment milieu in relation to stability of placement. Though this
study did assess a year of data, further longitudinal studies need to be conducted to understand
placement stability further.
Other research has examined the relationship between medications and behaviors.
Bellonci et al. (2013) sampled 531 youth who were admitted to two residential treatment
programs. Level of medication was recorded at time of admission, then medication levels were
assessed at time of departure. The researchers created four categories: medication reduction,
medication maintenance, no medication, and medication increase to understand the changes in
medication use over the course of the youths’ stays. Medication use data were compared to the
data collected for occurrence of assaultive behavior and physical restraints. Their findings
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indicate that the medication reduction group had the most substantial reduction in both assaults
and physical restraints. There was an average of 1.8 fewer psychical assaults and 1.1 fewer
physical restraints found in the medication reduction cohort (Bellocini et al. 2013). The sample
consisted of youth who were referred from higher levels of care and presented with a history of
assaultive behavior. The sample population was drawn from two separate treatment milieus, one
in the Midwest and one in New England (Bellocini et al. 2013). While these findings were taken
from a residential treatment program, they may not be generalizable to other treatment milieus.
In a study conducted by Huefner, Griffith, Smith, Vollmer, and Leslie (2014), 228 youth
were sampled from 2005 to 2007 at an intensive residential treatment center. Their findings
indicate that medications can be reduced for most youth without increased emotional and
behavioral problems. Among the population sampled, personal restraint was decreased
significantly for all groups except the medication increase group (Huefner et al. 2014). Important
implications of this research demonstrate the efficacy of necessary medication reduction. While
this study provides preliminary evidence of medication reduction efficacy, these reductions
occurred within a clinically-direct psychoeducational treatment environment. Further research
needs to be conducted to show if this phenomenon is consistent within other treatment milieus.
An important factor to be considered in a discussion of medication reduction is the principle of
sufficiency, which states treatment should involve minimally sufficient intervention (Huefner et
al. 2014). The goal of sufficiency is to solve a problem without creating dependency or
consequences. One way to practice sufficiency may be through medication reduction, prescribing
the least amount of medication necessary to achieve a desired treatment goal (Huefner et al.
2014).
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Policy/Guidelines
Understanding the factors affecting the mental health use of youth in foster care, it is
crucial to ensure an increased level of safe guards for this population. An important policy for
protocols and monitoring of medications for youth in foster care emerged in 2011 with the
passage of the Child and Family Services Improvement and Innovation Act. This act calls for
increased monitoring and complete documentation of services rendered by physicians to foster
care youth. The general principles of psychotropic medication prescription in a youth population
include (AACAP, 2001a, 2001b, 2004; Crismon et al., 2007):


A comprehensive evaluation before the medication prescription



A DSM-IV-TR psychiatric diagnosis before prescription



Counseling or psychotherapy should occur concurrently



Target symptoms and treatment goals should be identified



Consider side effects and benefit-to-risk ratio



Informed consent prior to medication use



Mental health and treatment literacy provided to patient and caregivers



All side effects documented



Appropriate monitoring of indices and labs



One medication change at a time



Dosage should start low and increased carefully



Appropriate clinician follow-up
Michigan guidelines. Congruent with an increased need for monitoring Michigan has

implemented guidelines for psychotropic medication use with the foster population. The
Michigan Department of Health and Human Services (DHHS, 2015) explicitly states that
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psychotropic medication may never be used as a behavior management tool outside of a
therapeutic goal. Prior to medication prescription youth must have a current physical, a mental
health assessment, and an appropriate information process explaining the purpose and effects of
medication use (DHHS, 2015). These implemented DHHS guidelines which were created by the
Texas Department of Family and Protective Services and The University of Texas at Austin
College of Pharmacy. These guidelines provide a base level direction for medication use. If
these guidelines are exceeded, the medication regimen will be reviewed by a DHHS medical
consultant (Crimson et al., 2007). Medication regimens requiring review due to exceeding
guidelines include:


prescribed four or more concomitant psychotropic medications



prescribed two or more concomitant anti-psychotics



prescribed two or more concomitant mood stabilizer medications



prescribed two or more concomitant anti-depressants



prescribed two or more concomitant stimulant medications



prescribed two or more concomitant alpha agonist medications



prescribed psychotropic medications in doses above recommended dose
These guidelines set forth are a starting point to address the mental health and medication

use disparities between foster youth and their peers. While the current guidelines provide for
some level of monitoring of psychotropic medication use, further policies and guidelines are
needed to ensure the protection of foster youth.
The multiple service systems experiences by foster care youth present challenges for the
diagnosis and treatment of mental illness in foster youth. To address the disparities present in
medication use and prevalence rates further research is needed. The safety of youth in foster care
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is paramount. Guidelines around medication utilization only begin to bridge the gap of disparity
experienced by foster care youth.
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CHAPTER 3: METHODOLOGY
The objective of this study is to understand foster care youth’s mental health and
psychotropic medication use while in care. Observing the medication use and the presentation of
negative behaviors may provide insight into practices of medication management and mental
health support that impact youth in foster care. This study seeks to answer the question: what are
foster care youth’s mental health and medication use while in placement? Specifically, this study
seeks to observe the relationship between decreased medication use and incidence of negative
behavior. This study uses quantitative research methods to observe the relationship between
medication use and presentation of negative behavior for foster youth in residential placement.
Participants
After receiving IRB approval (Appendix A), case files of foster youth were reviewed
(n=27). Using a convenience sample, 27 foster care case files were drawn from all discharge
youth who have resided in placement at a residential foster care facility in an urban city in a midwest state. This facility is home to 8-12 residents at one time and is an all-female facility. Youths
placed at this agency are between the ages of 11-18, and it has been in existence since February,
2014. The study site serves youth with legal statuses including temporary court wards and
permanent court wards.
Instrument
A case record review tool (Appendix B) was used for quantitative data collection. Data
collected includes demographics, medication use, conduct and incident reports, diagnosis and
change in diagnosis. All of the data collected was for the duration of time they spent in care at
the agency. Demographics included date of birth, date of intake, date of discharge, length of time
in out of home placement, number of previous placements, number of previous psychiatrist,
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number of previous counselors, number of previous hospitalizations, gender, and race/ethnicity.
Medication use was collected for dosage of each medication recorded by milligrams. Data was
collected each time a medication changed, including the new dosage of each medication
prescribed. Number of conduct reports were collected by month and incident reports were
recorded based on category of the incident. These categories include: incident, accident, illness,
medication, and AWOL reports. Data for each report type was collected by month for the
duration of time in care at the agency.
Data Analysis
After case file data was collected with the case record review tool, data was analyzed
using SPSS. For data analysis descriptive statistics and non-parametric bivariate analysis was
used to observe medication use and mental health in foster care youth. The dependent variable
was number of conduct reports. The independent variables were number of medication at intake
and number of medications at the end of the observation period. For analysis, the number of
medications prescribed was dichotomized to create a variable with only two categories (Field,
2009). With dichotomizing a new set of nominal variables and number of conduct reports written
was observed for analysis. For these variables, the non-parametric Mann-Whitney test was used
to observe the differences between two samples (Field, 2009). The study collected descriptive
statistics on diagnosis at intake, number of diagnoses, change in diagnosis, medication at intake,
medication changes, number of conduct reports, and number and kind of incident reports.
The collection and analysis of the case record review data will serve to understand
current practices employed around medication use in residential foster care.
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CHAPTER 4: RESULTS
Twenty-seven case files were reviewed for this study. Descriptive statistics were run on
specific case review questions to include participant’s demographics, diagnoses at intake,
diagnosis change, number of medications at intake, number of conduct reports, and number of
incident reports.
Demographics
All of the participants were female (N = 27), with 72% (N = 18) being African American.
Participants ranged in age from 9 to 18 years old with a mean age of 14.75 (SD = 2.17) with 83%
(N = 26) of participants between the ages of 13 and 18. The number of years in out-of-home
foster care ranged from less than a year to 16 years, with the average 4.52 years (SD = 4.92). Of
these years spent in out of home foster care, participants spent from 0-19 months residing at the
agency with an average stay of 4 months (SD = 4.72). This is a first foster placement for four
participants; although the mean number of previous placements was 8.42 (SD = 8.00), and one
youth had 29. Please refer to Table 1 for additional demographic information.
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Table 1
Sample Characteristics Distribution (N=27)
Variable
Age
Years in Foster Care
Number of Previous Placements
Number of Month At Agency
Race/Ethnicity
African American
Asian
White/Caucasian
Latino/a or Hispanic
Multiracial
Diagnosis at Intake

M(SD)
14.75(2.17)
4.52(4.92)
8.42(8.00)
4.00(4.72)

Frequency

Percent

18
2
6
1
2

62.06
6.89
20.68
3.44
6.89

A frequency distribution shows the mental health diagnosis at intake in Table 2. There
were a total of 62 total diagnoses at intake including 14 different diagnoses, as categorized by
the Diagnostic and Statistical Manuel of Mental Disorders (DSM-5). Diagnosis categories
included: disruptive, impulse control, and conduct disorders; personality disorders & mood
disorders;

depressive

disorders;

trauma

and

stress

disorders;

anxiety

disorders;

neurodevelopmental disorders; and bi-polar and related disorders. The most frequent diagnoses
at intake were post-traumatic stress disorder (PTSD) (N = 12) and mood disorder with (N = 10)
diagnoses at intake. Other prominent intake diagnosis include attention deficit hyperacidity
disorder (ADHD) (N = 8) and oppositional defiant disorder (N = 7).
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Table 2
Frequency Distribution of Intake Diagnosis (N=26)
Variable
Frequency
Disruptive, Impulse Control, and Conduct
Disorders
Oppositional Defiant Disorder
7
Conduct Disorder
5
Intermittent Explosive Disorder
1
Disruptive Behavior Disorder
1
Personality Disorder
Borderline Personality Disorder
1
Mood Disorders
Mood Disorder
10
Depressive Disorders
Major Depressive Disorder
3
Depression
2
Dysthymic Disorder
2
Trauma and Stress Disorders
PTSD
12
Adjustment Disorder
3
Reactive Attachment Disorder
1
Anxiety Disorders
Anxiety Disorder
1
Neurodevelopmental Disorders
ADHD
8
Bi-Polar and Related Disorders
Bipolar Disorder
No Diagnosis

5
2

Percent

10.94
7.81
1.56
1.56
1.56
15.63
4.69
3.13
3.13
18.75
4.69
1.56
1.56
12.50

7.81
3.13

The number of diagnoses at intake varied from no diagnosis (N = 2) up to 5 diagnoses (N
= 1). In this sample 69.23% (N =18) of participants had two of more diagnoses, and eight
participants who had four of more diagnoses.
Change in Diagnosis
There were no more than one change in diagnosis for each participant during the duration
of care at the agency. There were a total of 14 changes in diagnosis. The most common was an
additional diagnosis of PTSD in 21.43% (N=3). Other diagnosis changes included the diagnosis
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of ADHD, Bi-Polar, Conduct Disorder, and Major Depressive disorder occurred in less than 15%
(N=11) of cases during a diagnosis change.
Psychotropic Medications at Intake
The number of prescribed psychotropic medications ranged from none to four. Most
clients were prescribed two psychotropic medications 26.92% (N=7) zero medications 26.92%
(N=7). The medications participants were receiving at intake varied greatly. There were a total of
20 different psychotropic medications prescribed at the time of intake with a total of 45
psychotropic medication prescribed to 20 participants at the time of intake. As indicated in table
3, these medications were categorized by class: stimulants, anti-psychotics, anti-depressants,
mood stabilizers, and anti-hypertensive agents. The anti-hypertensive category encompassed one
medication that was a non-stimulant used to treat ADHD. The most common medications
prescribed, were Apriprazole (Abilify; N = 6), Trazadone (N = 7), and Quetiapine (Seroquel; N =
4). Sixty four percent (N = 32) of medications did not change during the course of care at the
agency. Twenty percent (N=10) decreased in dosage and 16% (N=8) increased in dosage during
the observation period. Two of the ten residents who experienced medication changes, had three
or more medication changes over the observation period.
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Table 3
Frequency Distribution of Psychotropic Mediations Prescribed At Intake (N=26)
Class
Name Frequency
Stimulants
Amphetamine
1
Methylphenidate
2
Lisdexamfetamine
1
Anti-psychotics
Aripiprazole
6
Quetiapine
4
Lurasidone
3
Olanzapine
1
Risperidone
2
Haloperidol
2
Fluphenazine
1
Anti-depressants
Citalopram
2
Fluoxetine
1
Imipramine
2
Sertraline
1
Trazadone
7
Vilazodone
1
Mood Stabilizers
Lithium
2
Valproate Semisodium
1
Benztropine
3
Anti-Hypertensive
Guanfacine
2
No Medications
7

Behavior Reports
At this agency, there were two forms of reports used to record behavioral incidents.
Conduct reports were used to report any negative behavior, while incident reports were used to
report events including: incidents, accidents, illness, medication errors, and absence without
legal permission (AWOLP).
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The agency opened its doors to serve foster youth February 2014, serving three clients. In
2014, there were a total of 15 conduct reports reported for three different participants. As the size
of the agency increased, so did the number of conduct repots. The agency’s capacity grew as
referrals were accepted for admits. In 2015, there were 97 conduct reports from a total of 12
participants, with an average of eight reports per participant. Conduct reports can serve as one
indicator of externalizing behaviors of youth.
As described in Table 4, there were two years of incident reports reviewed for previous
residents. While there were 61 incident reports in 2014, there was a slight increase to 69 reports
in 2015. Incident reports, classified as incident, accident, illness, medication errors, and other
decreased by nearly half from 2014 to 2015 (43 to 26 reports, respectively). There also were
slightly more AWOLP the first year at eight reports, compared to five in 2015. The location of
the incidents is consistent across both years, with 50 in 2014 and 59 in 2016 taking place at the
residential agency setting. Reports for medication errors increased from 3 in 2014 to 17 in 2015.
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Table 4
Frequency Distribution of Incident Reports
Variable
Type of Report
Incident
Accident
Illness
Medication Error
AWOLP
Other
Location of Report
Residential
School
Other (Appointment, Home Visit)
Bi-variate Analyses

2014

2015

43
3
3
3
8
1

26
5
6
17
5
0

50
9
2

59
4
6

The data collected was examined using non-parametric testing to observe the relationship
between given variables. Non-parametric testing fit for this study because the statistical
procedures that do not reply on the assumption of normal sampling distribution (Field, 2009).
The Mann-Whitney test used to look at the differences between two independent samples (Field,
2009).
Medication Prescription at Intake. In 2014, the number of conduct reports (Mdn = 0)
did not differ significantly from those participants who were taking medication at intake
(Mdn=2) U= 60.50, z= -.723, ns, r= .14. Furthermore, in 2015, the number of conduct reports
(Mdn= 0) did not differ significantly from those participants who were not taking medication at
time of intake. U= 65.50, z= -.274, ns, r= .05.
Medication Prescription at Discharge. In 2014, the number of conduct reports (Mdn =
0) did not differ significantly from those participants who were taking medication at discharge
(Mdn=2) U= 79.50, z= -.106, ns, r= -.02. Furthermore, in 2015 the number of conduct reports
(Mdn= 0) did not differ significantly from those participants who were taking medication at
discharge U= 80.50, z= -.028, ns, r=-.01.
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CHAPTER 5: DISCUSSION
This study was designed to observe the use of psychotropic medication and incidence of
conduct reports among youth in residential foster care. Observing the use of medication and
incidence of conduct both raise concern and provide insight into the experience of youth in care.
Diagnosis
There were two main variables that evaluate diagnosis, both at intake and at discharge.
There were 64 diagnoses at intake and an additional 14 diagnoses prior to discharge. The two
most prevalent diagnoses at intake were post-traumatic stress disorder (N =12) and mood
disorder (N =10), which is consistent with previous research with this population (Floersch et al.
2009). In the current study, diagnoses were mainly changed during hospitalization. Information
on diagnoses was limited during case file review, because many files did not have previous
psychiatric evaluations present, especially when residents were temporary court wards. Few
records reviewed held previous mental health history beyond the last psychiatric evaluation.
Many of the participants experienced comorbidity, which is the occurrence of two or
more simultaneous diagnoses. The occurrence of comorbidity was about 70% (N =18) in this
study. In Foltz and Huefner (2014), the rate of comorbidity was upwards of 90%. This large
disparity between studies could be attributed to the larger sample size in Foltz and Huefner’s
study (2014), who observed a total of 48 participants who received residential treatment. This
finding is important because it is consistent with literature indicating that youth in care
experience comorbidity at higher rates than their non-foster care peers (Foltz & Huefner, 2014).
The typical occurrence of multiple diagnoses for youth in care may be due in part to the
inconsistent and often disrupted mental health services for youth in care.
Medication Dosage and Use
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This study found high rates of medication prescription as well as practices of
polypharmacy, which is described as prescription of multiple medications concurrently and is
more common among foster care recipients (Zito et al. 2008). 342 or 73% of foster youth were
prescribed two or more medications from multiple medication classes for the same psychiatric
diagnoses. This is consistent with findings in other studies of foster youth in group homes where
77% of youth were prescribed psychotropic medication (Breland-Noble et al. 2004). The
findings in this study show a typically lower rate of polypharmacy than similar studies. A study
conducted by Brenner et al. 2004 found that 61% of youth in their sample were taking two or
more psychotropic medications, while this study recorded a rate of only 54%.

Similarly,

findings from another study show a polypharmacy rate of nearly 70% (Foltz & Huefner 2014).
This may be due in part to a higher rate of psychiatric diagnosis among foster care youth; this
study may have showed a lower incidence of polypharmacy due to a high admittance of
temporary court wards.
Conduct and Incident Reports
Conduct reports are one indicator use to assess to occurrence of negative behavior while
in care. In this study, there were much lower rates of conduct reports in 2014 than there was in
2015. In 2014, there were 15 conduct reports and in 2015, there were 97 conduct reports. This
may be in part to the greater number of residents as the agency grew, although it is notable that
two residents amassed over 15 conduct reports each for a total of 39 incident reports in 2015.
Further investigation may be useful to categorize the type of conduct report. While this kind of
categorization is not provided for on the conduct report form itself, it may provide greater
information into what kind of misconduct is occurring.
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There was a similar occurrence of incident reports in 2014, and 2015, (61, 69
respectively). In 2015 there were 17 medication errors as opposed to 3 reports for the previous
year. This maybe an underreporting for 2014, but an interesting finding. The vast majority of
incident reports were occurring at the residential facility, as opposed to at an appointment, home
visit, or a school setting. There were nine incidents reports at school in 2014, this may be due in
part to some residents attending school off campus, which was curtailed in 2015. Although
information was collected from incident reports, these reports span across multiple
categorizations. Further investigation is needed into the incident reports to understand if these
incidents were related to misbehavior. Due to the fact that most of the categories of incident
reports would not report misbehavior.
Bi-variate Analysis
Utilizing non-parametric data analysis the findings indicated that there was no statistical
significance between use of medication at intake and at discharge, in relation to the number of
conduct reports. The findings suggest that the number and aggregate dosage of medications each
participant was prescribed does not impact the occurrence of conduct reports among youth in this
observational study, which is consistent with Bellonci et al. (2013) who found that decreased
assaults and physical restraints were not correlated with decrease in psychotropic medication.
While there was not a statistically significant correlation found the medication reduction group
experienced the most reduction in assaults and restrains, their findings support this with 1.8
fewer assaults and 1.1 fewer restraints in their sample population (Bellonci et al. 2013). These
reductions may be due in part due to extraneous variables for example short length of stay and
multiple placements which is experienced by many youth in foster care. Although the sample in
this study was small the investigation into this relationship is important to understand how
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medication affects behavior, specifically to understand if medication reeducation reduces
occurrence of conduct reports. Given a larger sample size, a significant relationship may exist
between number of medications and number of conduct reports. Further investigation is needed
into what variables may facilitate these concurrent reductions.
Limitations
Although this study was able to observe mental health and medication use for foster care
youth, there are limitations that caution interpretation of findings. As a descriptive study, this
study reviewed the mental health and medication use while in residential care. Due to the small
sample size of 27 participants, statistics were limited to non-parametric statistics. This small
sample size was due to the nature of the facility. The residential facility is a private facility which
as a part of its mission keeps resident admission below 12 residents at a time. This factor limited
the amount of participants available in a two year observation period. This residential facility
has only been in operation since February 2014, and is only a preliminary view of previous
residents at this facility. With a longer observation period, more participants would be included
in the sample size that could have yielded more case file reviews. Furthermore, it was
determined that only previous residents would be included in this study, to protect confidentiality
of those residents currently at the facility. If current residents been included parametric statistics
could have been used.
Choosing to participate with a homogenous female only residential facility eliminated the
opportunity for the observation of mental health and medication use among the male population
in foster care. This study also utilized only quantitative case file review which does not address
the nature of foster care youth mental health experiences. With use of qualitative methods, the
experience of medication use and mental health experience in care may be better understood.
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Quantitative data in limited in its ability to explore the nuance behind the number which could be
used to further elucidate the research question. As a part of the case file review there were a few
variables that were included on the tool but were not collected due to the data not being available
in the case file reviews is expected. These variables of numbers of previous counselors,
psychiatrists, and hospitalizations may have provided insight into mental health history and
should be examined in future research.
Social Work Implications
The results of this study provide a look into mental health and medication use for youth
in care. Although the findings from this study were not statically significant, the descriptive
statistics described in this study provide a preliminary base of information and direction for
future studies. The findings provide important implications into social work practice, policy, and
social work education.
Practice. There are important implications from this study for social work practice. In
this study there was a high rate of polypharmacy. Seven youth were taking two or more
psychotropic medications concurrently. The occurrence of polypharmacy among youth is
common, yet there is efficacy and safety questions.

To address these safety concerns,

practitioners should take an active role in medication management, along with prescribing
psychiatrists, to ensure medications are prescribed when necessary but not overprescribed.
Utilizing sufficiency, “treatment should involve the minimally sufficient intervention to solve a
problem without creating dependency or unwanted consequences” (Huefner et al. 2014, pg.682).
Counseling should always be used as a first line course of treatment, especially when
medications are being utilized.
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Findings from this study indicate high levels of PTSD diagnosis. As an implication of
these findings, creating a comprehensive training around PTSD symptoms, treatment and
effective interventions would be beneficial to the sample population. Caregivers need to be
educated about the symptoms of PTSD to better recognize and respond to the effect of trauma
these youth have encountered. Clinical staff need to be trained in evidence-based interventions
for adolescents in order to effectively work with this population. Caregivers need to be trained
in how to effectively assist youth in manage symptoms. This training ensures that both care
givers and clinicians have appropriate knowledge of the primary diagnosis of this residential
population. Evidence-based training provides a base of knowledge for the behaviors management
instead of relying on medications alone.
Policy. Nationally efforts have been made through the 2011 Child and Family
Services Improvement and Innovation Act (AACAP, 2005). This act created policy for
protocols and monitoring of medications for youth in foster care. These provision help
narrow the gap between the pattern of medication use for youth in foster care placement and
their non-foster peers. The implemented guidelines involve proper evaluation, diagnosis,
statement of goals, informed consent, documentation of side effects, proper dosing, and
clinician follow up (AACAP, 2001a, 2001b, 2004; Crismon et al., 2007).
In this study’s findings youth experienced an average of eight placements during their
time in care. Improved oversight could have positive effects for continuity of care, placement
stability, reduced need for hospitalization, and decreased incidence of drug reactions and
interactions (Naylor et al. 2007). Youth placed in foster care would benefit from a consistent
interested party, for managing multiple services, this agent would ensure the safety and wellbeing of the child throughout the duration of their time in care. This is often not the case with
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high turnover rates with workers, placements, and limited interaction with GAL and judges. A
consistent party would provide further protection of youth in care particularly, their mental
health and well-being.
Michigan has already adopted guidelines for psychotropic medication use to ensure adequate
oversight for children in care, which includes a mechanism for medication review if guidelines
are exceeded (DHHS, 2015). For Michigan to be able to appropriately enforce these guidelines
there needs to be allocation of monies to these oversight committees. These policies in Michigan
are as follows:


prescribed four or more concomitant psychotropic medications



prescribed two or more concomitant anti-psychotics



prescribed two or more concomitant mood stabilizer medications



prescribed two or more concomitant anti-depressants



prescribed two or more concomitant stimulant medications



prescribed two or more concomitant alpha agonst medications



prescribed psychotropic medications in doses above recommended doses
There can be many barriers to creating more oversight of psychotropic medication. For

implementation to occur there must be resources allocated to enhance consent and finance
oversight processes. Resources need to be created such as practice guidelines, formularies,
and information on policies and procedures.
Social work education. There are two important implications of the study relating to
social work education. First, findings demonstrate the importance of considering human behavior
in the social environment. Symptoms of mental health do not occur in isolation, but are impacted
by environment. The outside environment is encompassing and not limited to relationships with
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family, peers, and romantic relationships. This would also include broader relationships with
schools, institutions and the community. This education would understand a youth in care in the
context in which they reside. This theoretical training teaches the importance of understanding
the social environment from which these youths come from. All of the variables reviewed in this
study are situated within this expansive context of the social environment experienced by each
youth in care. Understanding the implications of human behavior in social environment can help
social workers to understand that there are a multitude of experiences that has facilitated this
youth in care residence. This would help prepare future social workers in more effectively
working with children who been involved in multiple systems of care and underscore the
importance of cross system collaboration.
Recommendations for Future Research
Further research is needed with a larger sample of foster youth to understand if there is a
relationship between medication use and incidence of misconduct. While a quantitative study
provides statistical numerical evidence and possible correlations, there is also a need to
understand the mental health and medication experience from the youth’s perspective. The
findings of this study indicating high rates of medication use and multiple diagnoses, which
could be further understood through qualitative methods. Understanding the youth’s experience
of medication management, experience of side effects and the youth’s concerns about their use
of medication while in care, may provide greater insight in mental health experience of foster
youth. A mixed methods study would help elucidate the experiential part of mental health and
medication use for youth. Using both quantitative and qualitative methods would help
researchers to understand medication rates and statistical significant while concurrently using an
interview or a focus group with foster care youth to give first hand insight into their mental

37

health experiences. The quantitative data can be triangulated with the qualitative, to gain further
understanding of medication use and mental health services in care.
Additionally, research providing an intervention such as mindfulness would be a useful
tool to understand not only medication use in this population but other non-pharmaceutical
interventions to assist in the healing or the trauma many foster youth have experienced (Coholic
& Eys, 2016). There is a limited body of research available regarding the use of mindfulness
with foster care youth. Researching alternative interventions and understanding the effect
experienced, could led to the development of evidence-based practices around mindfulness
interventions. Providing more holistic means to care for traumatized individuals. These practices
may also reduce the number of medications foster youth are prescribed.
This exploratory study provides a brief examination of mental health and medication use
of foster care youth. Findings from this study provide a starting point for focusing on vulnerable
populations involved in multiple service systems of care, enabling a greater understanding of
what

having

mental

health

and

well-being

can

be

for

this

population.
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Nearly half of children in the child welfare system have clinically significant emotional
or behavioral issues (Bums et al., 2004; Leslie et al.,2004), and are medicated at higher rates than
their non-foster peers (e.g. Leslie et al., 2011; Zito et al.,2003). Research shows prescription of
multiple medications is also a common occurrence in foster care. The proposed study seeks to
answer the question: what are foster care youth’s mental health and medication use while in
placement? This research employs a quantitative descriptive study to examine medication and
conduct reports for foster youth in a residential placement.

Findings suggest there is no

correlation between medication use and conduct reports, although further research is needed to
understand what impact medication has on conduct and placement stability. Understanding
medication use and the presentation of behaviors provides insight into practices of medication
management and mental health support, which impacts youth in care.
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